Log In
Print
BCIQ
Print
Print this Print this
 

Serevent, salmeterol (xinafoate)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLong acting adrenergic receptor beta 2 agonist (LABA)
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today